-

Quantum Computers Have the Potential to be Faster and More Powerful Than Classical Computers - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--ResearchAndMarkets.com published a new article on the quantum computing industry "Quantum Computers Have the Potential to be Faster and More Powerful Than Classical Computers"

Quantum computing startup Rigetti Computing announced that it has closed a $79 million Series C funding round. The company currently offers cloud based access to its quantum machines. Quantum computers are built around the concept of quantum bits or qbits which give them the potential to be much faster and much more powerful than classical computers. While quantum computers may not yet be ready for real world use cases, the industry has made significant progress in recent years.

Microsoft and ETH Zurich recently developed a quantum algorithm that can simulate catalytic processes extremely quickly which could help to develop an efficient method for carbon fixation. This process reduces carbon dioxide in the atmosphere by turning it into useful compounds. IBM has joined with the University of Tokyo to create the Quantum Innovation Initiative Consortium (QIIC) to accelerate quantum computing research and development in Japan. QIIC members will have cloud access to the IBM Quantum Computation Center as well as access to a dedicated quantum system planned for installation in Japan in 2021.

To see the full article and a list of related reports on the market, visit "Quantum Computers Have the Potential to be Faster and More Powerful Than Classical Computers"

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Hexabromocyclododecane (CAS 25637-99-4) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Hexabromocyclododecane (CAS 25637-99-4) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029" report has been added to ResearchAndMarkets.com's offering. This report on Hexabromocyclododecane provides comprehensive insights, including general information, synonyms, chemical composition, safety, hazards, handling, storage, and toxicological and ecological details, along with transport information. This in-depth study serves as a v...

Commercial Gas Rice Cookers Market Report 2026: Revenues Set to Reach $2 Billion by 2032 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Commercial Gas Rice Cookers Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The Commercial Gas Rice Cookers Market is experiencing significant growth, evolving from USD 1.28 billion in 2025 to an anticipated USD 2.00 billion by 2032, driven by a CAGR of 6.52%. This market research report provides a comprehensive analysis of the commercial gas rice cooker sector, highlighting key drivers like foodservice efficiency, industria...

Artemisinin Combination Therapy Market to Grow by $194 Million During 2026-2032 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Artemisinin Combination Therapy Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The Artemisinin Combination Therapy (ACT) market exemplifies dynamic growth and promising potential in the treatment of malaria. Expected to increase from USD 386.40 million in 2025 to USD 608.26 million by 2032, supported by a steady CAGR of 6.69%, this market highlights the evolving landscape for modern antimalarial solutions. At the core of AC...
Back to Newsroom